Latest News for: bla

Edit

Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation

Pharmiweb 23 Dec 2025
Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation The ... HNSA), today announced the submission of a Biologics License Application (BLA) to the U.S.
Edit

Bengal SIR: Mamata Banerjee to hold meeting with TMC’s BLA on Monday

The Siasat Daily 22 Dec 2025
Kolkata. West Bengal Chief Minister Mamata Banerjee is set to hold an important meeting with the Trinamool Congress booth-level agents (BLAs) at Kolkata’s Netaji Indoor Stadium on Monday ... ​​ ... You can also download our app for Android and iOS. .
Edit

Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease

Nasdaq Globe Newswire 18 Dec 2025
Sangamo announces it has begun a rolling submission of its BLA to the FDA for , an investigational gene therapy for adults with Fabry disease ... .
Edit

01 13.12.2025 AGF Bla 01

Rumble 17 Dec 2025
Click the Rumble article link to see the video ....
Edit

BLA claims major strikes on Pakistani forces across Balochistan

Suryaa 03 Dec 2025
The spokesperson further stated that BLA fighters targeted a Pakistani army checkpost near Park Hotel in Turbat city with a grenade attack on the same day, causing casualties and property losses.
Edit

BLA bomber targets Pakistan paramilitary headquarters

The Hindu 02 Dec 2025
At least four persons, including North Waziristan Assistant Commissioner, and two policemen, were killed when militants ambushed his vehicle in Pakistan’s northwestern Province Khyber Pakhtunkhwa on Dec 2, police said ....
Edit

Three BLA militants killed as Pakistani forces foil attack on FC headquarters in Balochistan

The Hindu 01 Dec 2025
The incident took place when the militants attempted to storm the headquarters of Frontier Corps after a suicide bomber detonated himself at the main gate,” an official said ....
Edit

IASO Bio Announces BLA Approval of Fucaso (Equecabtagene Autoleucel) by the Hong Kong Department of Health for the Treatment of Relapsed or Refractory Multiple Myeloma

PR Newswire 27 Nov 2025
Prior BLA approval of Fucaso in Mainland China; Clinical evidence from the FUMANBA-1 registrational study (CTR20192510; NCT05066646) ... BLA approved by the National Medical Products Administration (NMPA) in June 2023; Macau, China.
Edit

Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease

Nasdaq Globe Newswire 21 Nov 2025
U.S. FDA has accepted Sangamo’s request for a rolling submission and review of the BLA for ST-920 in Fabry disease ... .
Edit

XBRANE UPDATES ON TIMING FOR RESUBMISSION OF THE BLA FOR ITS RANIBIZUMAB BIOSIMILAR CANDIDATE TO FDA (Xbrane Biopharma AB)

Public Technologies 19 Nov 2025
2025-11-19 08.00.00 CET Xbrane Biopharma AB - Inside information XBRANE UPDATES ON TIMING FOR RESUBMISSION OF THE BLA FOR ITS RANIBIZUMAB BIOSIMILAR CANDIDATE TO FDA ... These corrective actions must be completed before the FDA can approve Xbranes BLA.
×